However, several studies have found that there was only fair to moderate agreement for Ki67 testing between CNB and SRS, and that the κ value was much lower than ER, PR, and HER2 evaluation; this was mainly interpreted as sampling error or tumor heterogeneity [11, 12]. The gene discussed is ESR1; the disease is neoplasm.